zepbound tirzepatide - Search News

Order byBest matchMost fresh

Zepbound Beats Wegovy for Weight Loss

Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

· 1d

· 1d · on MSN

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

· 1d · on MSN

Here’s how much extra weight is lost with Zepbound over Wegovy

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

· 22h

First head-to-head trial found Zepbound beats Wegovy for weight loss

· 1d

New study compares Wegovy and Zepbound for the first time

Healio6h

Tirzepatide bests semaglutide for weight loss in adults with obesity

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, according to findings from the SURMOUNT-5 trial. As Healio previously reported,

Applied Clinical Trials Online1d

Tirzepatide Demonstrates Superior Weight Loss to Semaglutide in 72-Week Phase IIIb SURMOUNT-5 Trial

In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist tirzepatide (Zepbound) delivered significantly greater and sustained weight loss than semaglutide (Wegovy) over 72 weeks in adults with obesity or overweight and comorbidities.

TCTMD1d

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.